Dimethyl fumarate Accord Uniunea Europeană - română - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - fumarat de dimetil - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresoare - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Mylan Uniunea Europeană - română - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - fumarat de dimetil - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Uniunea Europeană - română - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - fumarat de dimetil - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Uniunea Europeană - română - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - fumarat de dimetil - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresoare - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Neuraxpharm Uniunea Europeană - română - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - fumarat de dimetil - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Apretude Uniunea Europeană - română - EMA (European Medicines Agency)

apretude

viiv healthcare b.v. - cabotegravir - infecții cu hiv - antivirale pentru uz sistemic - apretude is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 infection in high-risk adults and adolescents, weighing at least 35 kg (see sections 4. 2, 4. 4 și 5.

Dopegyt comprimate 250 mg Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

dopegyt comprimate 250 mg

egis pharmaceuticals plc - methyldopum - comprimate - 250 mg

Dopegyt 250 mg comprimate Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

dopegyt 250 mg comprimate

egis pharmaceuticals plc - methyldopum - comprimate - 250 mg

Vocabria Uniunea Europeană - română - EMA (European Medicines Agency)

vocabria

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - infecții cu hiv - antivirale pentru uz sistemic - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

HYPERVULSIN 30 mg/g România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

hypervulsin 30 mg/g

hyperion s.a. - romania - methylii nicotinas - unguent - 30mg/g - medicamente topice pentru dureri articulare si musculare alte preparate - topice